| Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619) |
|---|
| 08/16/2006 | EP1689403A2 Heteroaryl-hydrazone compounds |
| 08/16/2006 | EP1689387A2 Bicyclic inhibitors of mek and methods of use thereof |
| 08/16/2006 | EP1689380A2 Method for treating adamts-5-associated disease |
| 08/16/2006 | EP1689376A2 Diaryl urea derivatives in the treatment of protein kinase dependent diseases |
| 08/16/2006 | EP1689233A2 Bicyclic inhibitors of mek and methods of use thereof |
| 08/16/2006 | EP1689231A2 Insecticidal n-(heteroarylalkyl) alkanediamine derivatives |
| 08/16/2006 | EP1303188B8 Herbicidal agent |
| 08/16/2006 | EP1252160B1 Methanocarba cycloalkyl nucleoside analogues |
| 08/16/2006 | EP1107958B1 Pyrimidine compounds |
| 08/16/2006 | EP1087941B1 Thiolesters and uses thereof |
| 08/16/2006 | EP1019075B9 Beta 2-adrenergic receptor agonists |
| 08/16/2006 | CN1819829A Pyrimidine-2, 4-dione derivatives as gonadotropin-releasing hormone receptor antagonists |
| 08/16/2006 | CN1817883A New crystalline and amorphous form of a triazolo(4,5-d)pyrimidine compound |
| 08/15/2006 | US7091380 Bradykinin B1 antagonists or inverse agonists, for prophylaxis and therapy of pain and inflammation |
| 08/15/2006 | US7091344 Infrared dyes based on cyclobutanone and cyclopentanedione; ink jet inks |
| 08/15/2006 | US7091223 Autoimmune diseases; anticancer agents |
| 08/15/2006 | US7091210 Substituted 2-aminoacetamides and the use thereof |
| 08/15/2006 | US7091209 Dihydroxypyridmidine carboxylic acids as viral polymerase inhibitors |
| 08/15/2006 | US7091206 Process for producing pyrimidine derivative and intermediate thereof |
| 08/15/2006 | US7091204 Sulfonamides |
| 08/15/2006 | US7091202 4-arylspirocycloalkyl-2-aminopyrimidine carboxamide KCNQ potassium channel modulators |
| 08/15/2006 | US7091201 Arylalkane-sulfonamides having endothelin-antagonist activity |
| 08/15/2006 | CA2211612C [5-carboxamido or 5-fluoro]-[2',3'-unsaturated or 3'-modified]-pyrimidine nucleosides |
| 08/15/2006 | CA2201219C Process for the preparation of substituted pyrimidines |
| 08/10/2006 | WO2006083454A1 Multicyclic bis-amide mmp inhibitors |
| 08/10/2006 | WO2006083271A2 Substituted aryl acylthioureas and related compounds; inhibitors of viral replication |
| 08/10/2006 | WO2006083012A1 Method for producing pyrimidine compound |
| 08/10/2006 | WO2006083010A1 Process for production of 4-acetylpyrimidines and crystals thereof |
| 08/10/2006 | WO2006082952A1 Amide compound |
| 08/10/2006 | WO2006082495A1 Peroxisome proliferator activated receptor modulators |
| 08/10/2006 | WO2006082412A2 Multimers of pyrimidinone derivatives and their use as human neutrophil elastase inhibitors |
| 08/10/2006 | WO2006082373A1 Pyrimidine compounds having ties (tek) inhibitory activity |
| 08/10/2006 | WO2006082371A1 Pyrimidine compounds having tie2 (tek) inhibitory activity |
| 08/10/2006 | WO2006081741A1 Quinazoline compounds or their medical salts and preparation and medical usage thereof |
| 08/10/2006 | WO2006055404A3 Compounds for targeting mechanisms implicated in the progression of stroke |
| 08/10/2006 | US20060178410 Preparation of N-{2-[4-(3-phenyl-4-methoxyphenyl)aminophenyl]ethyl}-2-hydroxy-2-(3-hydroxymethyl-4-hydroxyphenyl)ethylamine, for example; for the treatment of pulmonary diseases such as asthma and chronic obstructive pulmonary disease |
| 08/10/2006 | US20060178388 Phenyl-substituted pyrimidine compounds useful as kinase inhibitors |
| 08/10/2006 | US20060178384 2-(2,6-dimethoxy-phenylamino)-9-methoxy-6,7-dihydro-pyrimido[6,1-a]isoquinolin-4-one; 3-bromo-N-[3-(9-methoxy-4-oxo-6,7-dihydro-4H-pyrimido[6,1-a]isoquinolin-2-ylamino)-phenyl]-benzamide; kinase inhibitor; neutropenia; cytopenia; anemias |
| 08/10/2006 | US20060178376 Novel process for the preparation of hexacyclic compounds |
| 08/10/2006 | US20060178365 Optionally oxidized 6-(2-(5-methylthio-2-pyrimidinyloxy)ethoxy)-2-phenylpyrimidin-4-yl-substituted sulfamides |
| 08/10/2006 | US20060177621 O-coordinated metal chelates and their use in optical recording media having high storage capacity |
| 08/10/2006 | CA2596368A1 Diketo acids with nucleobase scaffolds: anti-hiv replication inhibitors targeted at hiv integrase |
| 08/10/2006 | CA2595801A1 Multimers of pyrimidinone derivatives and their use as human neutrophil elastase inhibitors |
| 08/10/2006 | CA2589328A1 Multicyclic bis-amide mmp inhibitors |
| 08/10/2006 | CA2566809A1 Substituted aryl acylthioureas and related compounds; inhibitors of viral replication |
| 08/09/2006 | EP1688410A1 Crystal of phenylalanine derivative and process for producing the same |
| 08/09/2006 | EP1688408A2 Vanilloid receptor ligands and their use in treatments |
| 08/09/2006 | EP1687857A1 Organic electroluminescent element |
| 08/09/2006 | EP1687284A2 p-38 KINASE INHIBITORS |
| 08/09/2006 | EP1687002A1 Fused heterocyclic compounds |
| 08/09/2006 | EP1686996A1 Quinazolinone compounds with reduced bioaccumulation |
| 08/09/2006 | EP1572666B1 3h-quinazolin-4-one derivatives |
| 08/09/2006 | EP1363637B1 Pyrimidine compounds and methods for their preparation |
| 08/09/2006 | EP1032393B1 Quinoline-containing alpha-ketoamide cysteine and serine protease inhibitors |
| 08/09/2006 | CN1816532A Heterocyclically-substituted pentanol derivatives, process for their production and their use as anti-inflammatory agents |
| 08/09/2006 | CN1816370A 17-acetamido-4-azasteroid derivatives as androgen receptor modulators |
| 08/09/2006 | CN1815771A Erasable, readable molecular-base electric double-stable negative-resistance component |
| 08/09/2006 | CN1814597A New method for preparing voriconazole |
| 08/09/2006 | CN1813723A Application of gaba-receptor modulators for the preventing/or treatment of neurodegenerative diseases of the eye |
| 08/09/2006 | CN1268627C Process for preparing 1.8-diazadicyclo [5,4,0] -7 undecene |
| 08/09/2006 | CN1268615C Substituted benzoylcyclohexenones |
| 08/09/2006 | CN1268610C Sulfonamide derivatives |
| 08/09/2006 | CN1268339C Use of rosuvastatin (ZD-4522) in the treatment of heterozygous familial hypercholesterolemia |
| 08/08/2006 | US7087644 Cardiovascular disorders; stimulant of guanylate cyclase ; therapy for liver fibrosis |
| 08/08/2006 | US7087617 Psychological disorders; anxiolytic agents; central nervous system disorders; antidepressants |
| 08/08/2006 | US7087616 Pesticides; insecticides; fungicides |
| 08/08/2006 | US7087613 Treating abnormal cell growth with a stable polymorph of N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine hydrochloride |
| 08/08/2006 | US7087612 Amine oxidase inhibitor; therapy for Alzheimer's diseases, Parkinson's disease |
| 08/08/2006 | US7087416 Across biological membranes of living cells; screening test chemicals that modulate a target ion channel; using fluorescence resonance energy transfer (FRET) |
| 08/03/2006 | WO2006081337A2 Erastin analogues and their uses for killing cancer cells |
| 08/03/2006 | WO2006080519A1 Diamine derivative |
| 08/03/2006 | WO2006079833A1 Quinazoline derivatives as antiviral agents |
| 08/03/2006 | WO2006079791A1 Chemical compounds |
| 08/03/2006 | WO2006079656A1 Hiv inhibiting 2-( 4-cyanophenylamino) pyrimidine derivatives |
| 08/03/2006 | WO2006079611A1 Crystalline forms of rosuvastatin calcium salt |
| 08/03/2006 | WO2006079556A2 Substituted 5-phenyl pyrimidines i in therapy |
| 08/03/2006 | WO2006079504A2 Process for the manufacture of a precursor of vitamin b1 |
| 08/03/2006 | WO2006061417A3 Macrocyclic quinazole derivatives and their use as mtki |
| 08/03/2006 | WO2006035277A3 Novel processes for preparing amorphous rosuvastatin calcium and a novel polymorphic form of rosuvastatin sodium |
| 08/03/2006 | WO2005060456A8 Method for treating adamts-5-associate disease |
| 08/03/2006 | US20060173181 8-Quinolinxanthine and 8-isoquinolinxanthine derivatives as PDE 5 inhibitors |
| 08/03/2006 | US20060173044 Substituted propargylamines |
| 08/03/2006 | US20060173022 Heterocyclic amides, method for the production thereof, substances containing said heterocyclic amides, and use thereof as pesticides |
| 08/03/2006 | US20060173003 4-Heteroarylamino-7-H(hetero)aryl-substituted, e.g., [6-(propane-2-sulfonyl)-pyridin-3-yl]-[7-(3-trifluoromethyl-pyridin-2-yl)-quinazolin-4-yl ]-amine hydrochloride; the compounds inhibit binding of vanilloid ligands to capsaicin receptors and are used to treat neuropathic pain |
| 08/03/2006 | DE102005003475A1 Neuartige Anbindung organischer Moleküle an eine Siliziumoberfläche zur Herstellung von Speicherelementen mit organischen Bestandteilen Novel attachment of organic molecules on a silicon surface for the production of memory elements with organic ingredients |
| 08/03/2006 | CA2599228A1 Hiv inhibiting 2-( 4-cyanophenylamino) pyrimidine derivatives |
| 08/03/2006 | CA2596237A1 Diamine derivative |
| 08/03/2006 | CA2595958A1 Substituted 5-phenyl pyrimidines i in therapy |
| 08/03/2006 | CA2595855A1 Pyrazine compounds for inflammation and immune-related uses |
| 08/03/2006 | CA2595848A1 Erastin and erastin binding proteins, and uses thereof |
| 08/03/2006 | CA2594708A1 Chemical compounds |
| 08/03/2006 | CA2594692A1 Crystalline forms of rosuvastatin calcium salt |
| 08/02/2006 | EP1686120A2 Methods and compositions utilizing quinazolinones |
| 08/02/2006 | EP1686119A1 Pyrimidine-4-one derivatives as ldl-pla2 inhibitors |
| 08/02/2006 | EP1685132A1 A sb 2B /sb ADENOSINE RECEPTOR ANTAGONISTS |
| 08/02/2006 | EP1685131A1 Hydroxyalkyl substituted pyrido-7-pyrimidin-7-ones |
| 08/02/2006 | EP1685119A1 N-acylsulfonamide apoptosis promoters |
| 08/02/2006 | EP1685116A1 Quinazoline derivatives |
| 08/02/2006 | EP1685115A1 Novel norepinephrine reuptake inhibitors for the treatment of central nervous system disorders |
| 08/02/2006 | EP1412362B1 THIENO¬2,3-d|PYRIMIDINEDIONES AS INHIBITORS OF T-CELLS PROLIFERATION |